Showing 1 posts of 1 posts found.


Zynerba’s cannabis-based transdermal patch fails at Phase 1, shares slide 21%

July 6, 2018
Medical Communications, Research and Development GW Pharma, Zynerba, cannabidinol, cannabinol, cannabis, pharma, trial failure

As public focus on the issue of medicinal cannabis continues to grow, Zynerba Pharmaceuticals has announced that its transdermal tetrahydrocannabinol …

Latest content